Granules India Ltd.

₹456.0

Granules India Ltd.

₹456.0

₹456.0

0.4 (0.09%) - 30 Apr 2025 01:50 PM

About Company

Granules India Limited is one of the vertically integrated, high-growth pharmaceutical manufacturing company in India. Based out of Hyderabad, India, it is into manufacturing Active Pharmaceutical Ingredients (APIs), Pharmaceutical Formulation Intermediaries (PFIs) and Finished Dosages (FDs). The company’s product-focused, vertically integrated business model has created a leadership position in several generic drugs. It has a strong presence in ‘first line of defence’ products, including Paracetamol, Ibuprofen, Guaifenesin and Metformin.

Market Cap. ₹11,050 Cr.
52 Week - High/Low ₹721/389
P/E Ratio 34.23
P/B Ratio 3.55
Enterprise Value ₹10,946 Cr.
ROE % 15.08
RSI Value 42.40
EMA 50 491.34
EMA 200 522.53
Market Cap. ₹11,050 Cr.
52 Week - High/Low ₹721/389
P/E Ratio 23.05
P/B Ratio 3.43
Enterprise Value ₹10,838 Cr.
ROE % 13.46
RSI Value 42.40
EMA 50 491.34
EMA 200 522.53

Growth

Valuation

Calculators

Peer Comparison

Industry - Pharmaceuticals & Drugs

* Please refer to the Standalone data if Consolidated financial data for the company is not available.

Shareholding Pattern Numbers in percentages

Insight market
Copyright © 2025 All rights reserved with INVESMATE INSIGHTS PRIVATE LIMITED | All logos and Trademarks registered with their respective owners.